switching from tirzepatide to semaglutide for weight loss glp 1 agonists between GLP‐1 receptor in clinical practice: Expert consensus and practical guidance Switching Between and Tirzepatide: – GLP-1 Medications for Weight Loss:

doi: 10.1053/j.gastro.2016.09.062 5

Wegovy (semaglutide) is a GLP-1 receptor agonist specifically approved for chronic weight management in individuals with obesity or overweight individuals with weight-related conditions

Speaking in Chicago at ASCO, Dr Mitchell Lazar, the director of the institute for diabetes, obesity and metabolism at the University of Pennsylvania School of Medicine, said: GLP-1 based therapies are highly effective at producing weight loss, and thus one of the fundamental mechanisms by which they improve cancer outcomes is via the impressive weight loss that they produce

Storage requirements: Store all unopened vials in the refrigerator at 36F to 46F (2C to 8C)